New methods for diagnosing and treating type 2 diabetes nephropathy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on the serious complications of diabetic nephropathy in patients with type 2 diabetes. It aims to establish a long-term follow-up system that utilizes sensitive biomarkers, imaging techniques, and digital markers to comprehensively assess the progression of the disease. By developing a multimodal non-invasive diagnostic model and a new clinical staging system, the research seeks to create an accurate diagnosis and treatment framework that integrates both traditional Chinese and Western medicine approaches.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Age ≥ 18 years old, regardless of gender; Type 2 diabetes; Having a complete medical history and clinical data; If the patients with type 2 diabetes combined with CKD underwent renal biopsy, the pathological diagnosis should be clear; Patients voluntarily signs an informed consent form.

Exclusion criteria:

Incomplete medical history or clinical data; Patients with hereditary kidney disease; Combined urinary tract infection; Merge autoimmune system diseases; Patients with malignant tumor were expected to survive less than 6 months; Pregnancy and lactation.

Where it's running

• Chinese PLA General Hospital
  Beijing, China Recruiting

Study contacts

• Study coordinator: Zheyi Dong, MD
• Email: shengdai26@163.com
• Phone: +86 010 66935462

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Pharmacist prescribing to improve kidney care for people with type 2 diabetes

  This project will test whether pharmacist prescribing guided by step-by-step algorithms helps adults with type 2 diabetes and early diabetic kidney disease who lack a regular doctor start recommended kidney‑protecting medications.

  Recruiting Nova Scotia Health Authority · Halifax, Nova Scotia · NCT07169422

• Effects of SGLT2 inhibitors on kidney function in Type 2 diabetes

  This study is testing if the diabetes medication Canagliflozin can help protect kidney function in adults with Type 2 diabetes and early signs of kidney disease.

  Recruiting Phase 4 University of Michigan · Ann Arbor, Michigan · NCT06291155

• Implementing diabetes treatment guidelines by primary care physicians in the community

  This study is testing whether following new diabetes treatment guidelines can help older adults with diabetes avoid serious heart and kidney problems compared to regular care.

  Recruiting at 13 sites Shanghai Zhongshan Hospital · Suzhou, Jaingsu and 12 other locations · NCT05349955

• Acute Blood Flow Restriction Walking in Type 2 Diabetes

  This study tests whether adding blood flow restriction to treadmill walking affects immune cells in adults with type 2 diabetes.

  Recruiting University of British Columbia · Kelowna, British Columbia · NCT07928531

• Continuous Glucose Monitoring in Type 2 Diabetes Not on Insulin

  This study tests whether using a continuous glucose monitoring system helps people with type 2 diabetes who aren’t using insulin to improve blood sugar control and quality of life.

  Recruiting Medical University of Bialystok · Bialystok · NCT07919236

• Differentiating heart disease in autoimmune vs. type 2 diabetes

  This study tests whether adult-onset autoimmune diabetes (AID/LADA) and type 2 diabetes (T2D) differ in how diabetic heart disease develops, using advanced heart imaging in people with AID, T2D, and healthy controls.

  Recruiting University of Roma La Sapienza · Rome, Roma · NCT07911007

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.